Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
The rest period is part of the protocol, not optional
The studied dosing starts low (about 2 mg weekly) and is increased roughly every four weeks to a target dose, with 12 mg being the highest dose in the main Phase 2 obesity trial
In the athletic world, the World Anti-Doping Agency (WADA) added BPC-157 to its Prohibited List in 2022 under the S0 category of Non-Approved Substances. This means its use is banned at all times for athletes competing under WADA-affiliated organizations
A 10 mg vial provides roughly one week of dosing at the lower maintenance range
Other side effects may include headaches, dizziness, fatigue, and injection site reactions
US$ 25.95
US$ 27.97
US$ 24.67
US$ 23.71
US$ 24.94
US$ 21.10
US$ 29.48
